Genetics of inflammation and risk of coronary artery disease: The central role of interleukin-6

European Heart Journal

Volumn 21, Issue 19, 2000, Pages 1574-1583

  Woods, A ^a   Brull, D J ^a   Humphries, Steve E ^a   Montgomery, H E ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; FIBRINOGEN; INTERLEUKIN 6;

CORONARY ARTERY DISEASE; HUMAN; INFLAMMATION; LEUKOCYTE MIGRATION; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THROMBOCYTE; VASCULAR ENDOTHELIUM;

EID: 0033804558     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1999.2207     Document Type: Review

References (110)

1. Atherosclerosis - An inflammatory disease
2. Dental disease, fibrinogen and white cell count; links with myocardial infarction?
3. Association between dental health and acute myocardial infarction
4. Missing teeth and ischaemic heart disease in men aged 54-64 years
5. Periodontal disease and cardiovascular risk
6. Helicobacter pylori infection: Relation with cardiovascular risk factors, ischaemic heart disease and social class
7. Relation of helicobacter pylori infection and coronary heart disease
8. Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men
9. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
10. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease
11. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study
12. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease
13. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery
14. Chlamydia pneumoniae: Risk factors for seropositivity and association with coronary heart disease
15. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-thickening, a measure of subclinical atherosclerosis
16. Cytomegalovirus and atherosclerosis
17. Is atherosclerosis an immunologically mediated disease?
18. Associations between plasma fibrinogen levels and cardiovascular risk factors in hypertensive men
19. C reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study
20. Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged man
21. Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers
22. Plasma fibrinogen and coronary risk factors: The Scottish Heart Health Study
23. Risks and mechanisms of cardiovascular events in users of oral contraceptives
24. Changes in haemostasis after stopping the combined contraceptive pill: Implications for major surgery
25. Hemostasis profile in women taking low dose oral contraceptives
26. Hormonal contraception, benefits versus risk
27. Oral contraceptives, fibrinogen and cardiovascular risk
28. The acute rise in plasma fibrinogen concentration with exercise is influenced by the G-453-polymorphism of the beta-fibrinogen gene
29. Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion
30. Physical exertion as a trigger of acute myocardial infarction
31. Physical activity and risk of peripheral arterial disease in the general population: Edinburgh Artery Study
32. Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults
33. Inverse relationship between physical activity and plasma fibrinogen in postmenopausal women
34. Exercise in leisure time: Coronary attack and death rate
35. Leisure time physical activity and coronary heart disease: The US railroad Study
36. Vigorous exercise in leisure time and the incidence of coronary heart disease
37. Lifelong exercise and stroke
38. Physical activity and stroke in British middle aged men
39. Physical fitness and cardiovascular disease mortality: The US Railroad Study
40. Physical activity, all-cause mortality, and longevity of college alumni
41. A meta-analysis of physical activity in the prevention of coronary heart disease
42. Postmenopausal estrogen therapy and cardiovascular disease: Ten-year follow-up from the Nurse's Health Study
43. Effects of estrogen/ progestin regimens on heart disease risk factors in postmenopausal women
44. Sex differences in susceptibility to etiologic factors for peripheral atherosclerosis. Importance of plasma fibrinogen and blood viscosity
45. Serum glycoproteins and severity of coronary atherosclerosis
46. Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin
47. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain
48. Elevation of C-reactive protein in 'active' coronary artery disease
49. Significance of adventitial inflammation of the coronary artery in patients with unstable angina: Results of autopsy
50. Plasma protein acute phase response in unstable angina is not induced by ischemic injury
51. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men
52. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on thrombosis and Disabilities Angina Pectoris Study Group
53. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischaemic heart disease. The Caerphilly and Speedwell Collaborative Heart Disease Studies
54. Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivors
55. Fibrinogen and risk of cardiovascular disease. The Framingham Study
56. Plasma fibrinogen - A major coronary risk factor
57. Fibrinolytic activity, clotting factors and long term incidence of ischaemic heart disease in the Northwick Park Heart Study
58. Hemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study
59. Fibrinogen as a risk factor for stroke and myocardial infarction
60. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the cardiovascular Health Study and the Rural health Promotion project
61. Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature
62. The biology of interleukin-6
63. Interleukin- is the major regulator of acute phase protein synthesis in adult human hepatocytes
64. Mortality risk associated with elevated interleukin-6 and C-reactive protein in old age
65. Elevated levels of IL-6 in unstable angina
66. Elevated levels of C-reactive protein at discharge predicts recurrent instability in patients with unstable angina
67. Increasing levels of interleukin (IL)-IRa and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events
68. C-reactive protein levels as a direct indictor of interleukin-6 levels in humans in vivo
69. Cigarette smoking influences cytokine production and anti-oxidant defenses
70. The cytokine response to strenuous exercise
71. Exposure to physical and psychological stressors elevates plasma interleukin-6: Relationship to the activation of the hypothalamic-pituitary-adrenal axis
72. The effects of psychological stress on humans: Increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety
73. Influence of psychological stress on immune-inflammatory variables in normal humans Part II. Altered serum concentrations of natural anti-inflammatory agents and soluble membrane antigens of monocytes and T lymphocytes
74. Inequalities in death-specific explanations of a general pattern?
75. Social inequality in coronary risk: Central obesity and the metabolic syndrome: Evidence from the Whitehall II Study
76. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis
77. A common polymorphism in the promotor region of the interleukin-6 (G-176-C) is strongly protective against myocardial infarction at a young age
78. Some basic facts about fibrinogen - An introduction
79. The human beta fibrinogen promotor contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element
80. Identification of β-chain domains involved in human fibrinogen assembly
81. Regulation of fibrinogen assembly: Transfection of hep G2 cells with β-cDNA specifically enhances synthesis of the three component chains of fibrinogen
82. European Atherosclerosis Research Study: Genotype at the fibrinogen Locus (G455-A beta-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence for gender-genotype-environment interaction
83. Polymorphisms of the beta fibrinogen gene and plasma fibrinogen concentration in Caucasian and Japanese population samples
84. Variation in the promotor region of the β-fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers
85. Impact of polymorphisms in the alpha- and beta-fibrinogen gene on plasma fibrinogen concentrations of coronary heart disease patients
86. Genetic variation at the β-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM study
87. Fibrinogen genotype and risk of peripheral atherosclerosis
88. Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms. G/A-455 (HaeIII), C/T-148 (Hind III/Alu), T/G+ 1639 (Ava II) and BcII (β-fibrinogen) and TaqI (a-fibrinogen) and their detection by PCR
89. Linkage disequilibrium relationships among four polymorphisms within the human fibrinogen gene cluster
90. Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes
91. Effects of changes in smoking and other characteristics on clotting factors and the risk of disease
92. Variability over time of haemostatic and other cardiovascular risk factors in patients suffering from angina pectoris. ECAT Angina Pectoris Study Group
93. Influence of fibrin, fibrinogen and fibrinogen degradation products on cultures endothelial cells
94. Effects of fibrin and fibrinogen-degradation products on the growth of rabbit aortic smooth muscle cells in culture
95. Platelet adhesion
96. Platelet activation induced by interleukin-6: Evidence for a mechanism involving arachadonic acid metabolism
97. The multiple levels of endothelial cell-coagulation factor interactions
98. Infection, inflammation and infarction: Does acute endothelial dysfunction provide a link?
99. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment
100. Induction by IL-1 and interferon-γ: Tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1)
101. Platelet-derived interleukin-1 induces human endothelial adhesion molecule expression and cytokine production
102. Expression of inflammatory mediators and adhesion molecules in human atherosclerotic plaques
103. Alterations in circulating intercellular adhesion molecule-1 and L-selectin: Further evidence for chronic inflammation in ischaemic heart disease
104. Subcutaneous adipose tissue releases interluekin-6, but not tumour necrosis factor-a, in vivo
105. Lipoproteins and atherogenesis: Current concepts
106. Interluekin-6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: A possible role for interleukin-6 in cancer cachexia
107. Altered serum lipid profile after systemic infection in children: Risk factor for CHD?
108. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue?